MONTREAL, QUEBEC-- - Paladin Labs Inc. and Nycomed Canada Inc., a subsidiary of Nycomed today announced that the companies have entered into a Canadian Co-Promotion Agreement for Tridural once-daily tramadol.
[News Source]
[News Source]
Blogosphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg


